BIOVENTUS_LOGO.png
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07, 2024 16:15 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
BIOVENTUS_LOGO.png
Bioventus Reports Second Quarter Financial Results
August 06, 2024 07:30 ET | Bioventus, Inc.
Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9%Q2 Gross Margin Expanded 350 bps and Adjusted Gross Margin* 180 bpsCash from Operations of $15.2 million Increased 40.5%Raising Full-Year 2024...
BIOVENTUS_LOGO.png
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
July 30, 2024 07:30 ET | Bioventus, Inc.
DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Reports First Quarter Financial Results
May 07, 2024 07:00 ET | Bioventus, Inc.
Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3%Gross...
BIOVENTUS_LOGO.png
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
April 29, 2024 07:30 ET | Bioventus, Inc.
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024 07:30 ET | Bioventus, Inc.
Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...
BIOVENTUS_LOGO.png
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
March 04, 2024 08:00 ET | Bioventus, Inc.
DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
January 18, 2024 16:15 ET | Bioventus, Inc.
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...
BIOVENTUS_LOGO.png
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
January 12, 2024 16:15 ET | Bioventus, Inc.
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on...
BIOVENTUS_LOGO.png
Bioventus Names Robert Claypoole as President and Chief Executive Officer
December 19, 2023 16:30 ET | Bioventus, Inc.
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of...